GlassScriptPhysician profile
Theodore T Manson
NPI 1760537666
$110,094.38
in general payments reported to CMS, 2019-2025
10 companies · $31K in 2025
The $31K reported for 2025 was more than what 93% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $6,114 · 2021: $72.84 · 2022: $22K · 2023: $20K · 2024: $6,301 · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $36K · Consulting Fee: $21K · Travel and Lodging: $928 · Food and Beverage: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $35,561.88 |
| Consulting Fee | $21,275.00 |
| Travel and Lodging | $927.55 |
| Food and Beverage | $253.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $53,956.71 | 2019-2025 | External Fixation, Arbor, Autobahn |
| Medical Device Business Services, INC. | $27,582.32 | 2019-2025 | Na |
| Depuy Synthes Products, INC. | $12,720.60 | 2019-2025 | |
| Stryker Corporation | $10,431.83 | 2019-2023 | Axsos |
| Synthes Gmbh | $5,103.80 | 2019 | |
| Depuy Synthes Sales INC. | $129.90 | 2025 | |
| Bone Support INC. | $91.64 | 2019 | |
| Supreme Orthopedic Systems, LLC | $38.20 | 2023 | |
| Horizon Therapeutics Plc | $22.15 | 2023 | Krystexxa |
| Pacira Therapeutics, INC. | $17.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theodore Manson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.